Literature DB >> 23206117

Non-adherence to new oral anticoagulants: a reason for concern during long-term anticoagulation?

R A Rodriguez, M Carrier, P S Wells.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23206117     DOI： 10.1111/jth.12086

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  24 in total

1.  Real-world complexity of atrial fibrillation treatment with oral anticoagulants: design and interpretation of pharmacoepidemiological studies.

Authors:  Andreas D Meid; Sarah Mächler; Walter E Haefeli; Gerd Mikus
Journal:  Br J Clin Pharmacol       Date:  2017-07-21       Impact factor: 4.335

2.  Effects of policy interventions on the introduction of novel oral anticoagulants in Stockholm: an interrupted time series analysis.

Authors:  Joris Komen; Tomas Forslund; Paul Hjemdahl; Morten Andersen; Björn Wettermark
Journal:  Br J Clin Pharmacol       Date:  2016-11-30       Impact factor: 4.335

3.  Prescribing of NOACs has outnumbered warfarin: exploring how physicians choose anticoagulant treatments.

Authors:  Anne Katrine Eek; Erik Øie; Anne Gerd Granas
Journal:  Eur J Clin Pharmacol       Date:  2017-11-17       Impact factor: 2.953

4.  Once versus twice daily direct oral anticoagulants in patients with recent stroke and atrial fibrillation.

Authors:  Alexandros A Polymeris; Annaelle Zietz; Fabian Schaub; Louisa Meya; Christopher Traenka; Sebastian Thilemann; Benjamin Wagner; Lisa Hert; Valerian L Altersberger; David J Seiffge; Flurina Lyrer; Tolga Dittrich; Ines Piot; Josefin Kaufmann; Lea Barone; Ludvig Dahlheim; Sophie Flammer; Nikolaos S Avramiotis; Nils Peters; Gian Marco De Marchis; Leo H Bonati; Henrik Gensicke; Stefan T Engelter; Philippe A Lyrer
Journal:  Eur Stroke J       Date:  2022-05-10

5.  Beliefs about medicines in Dutch acenocoumarol and phenprocoumon users.

Authors:  Talitha I Verhoef; W Ken Redekop; Marcel L Bouvy; Brenda Dorenbos; Zamiera Karwar; Rianne M F van Schie; Anthonius de Boer; Anke-Hilse Maitland-van der Zee
Journal:  Br J Clin Pharmacol       Date:  2014-08       Impact factor: 4.335

6.  Patients' knowledge on oral anticoagulant treatment in Hungary.

Authors:  Reka Viola; Helga Fekete; Ildiko Csoka
Journal:  Int J Clin Pharm       Date:  2017-10-19

7.  Association Between Use of Antithrombotic Medication and Hematuria-Related Complications.

Authors:  Christopher J D Wallis; Tristan Juvet; Yuna Lee; Rano Matta; Sender Herschorn; Ronald Kodama; Girish S Kulkarni; Raj Satkunasivam; William Geerts; Anne McLeod; Steven A Narod; Robert K Nam
Journal:  JAMA       Date:  2017-10-03       Impact factor: 56.272

Review 8.  Methodological considerations for investigating oral anticoagulation persistence in atrial fibrillation.

Authors:  Miney Paquette; Lawrence Mbuagbaw; Alfonso Iorio; Robby Nieuwlaat
Journal:  Eur Heart J Cardiovasc Pharmacother       Date:  2021-05-23

Review 9.  Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2.

Authors:  Hans-Christoph Diener; James Aisenberg; Jack Ansell; Dan Atar; Günter Breithardt; John Eikelboom; Michael D Ezekowitz; Christopher B Granger; Jonathan L Halperin; Stefan H Hohnloser; Elaine M Hylek; Paulus Kirchhof; Deirdre A Lane; Freek W A Verheugt; Roland Veltkamp; Gregory Y H Lip
Journal:  Eur Heart J       Date:  2017-03-21       Impact factor: 29.983

10.  Dabigatran - a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs.

Authors:  Rickard E Malmström; Brian B Godman; Eduard Diogene; Christoph Baumgärtel; Marion Bennie; Iain Bishop; Anna Brzezinska; Anna Bucsics; Stephen Campbell; Alessandra Ferrario; Alexander E Finlayson; Jurij Fürst; Kristina Garuoliene; Miguel Gomes; Iñaki Gutiérrez-Ibarluzea; Alan Haycox; Krystyna Hviding; Harald Herholz; Mikael Hoffmann; Saira Jan; Jan Jones; Roberta Joppi; Marija Kalaba; Christina Kvalheim; Ott Laius; Irene Langner; Julie Lonsdale; Sven-Äke Lööv; Kamila Malinowska; Laura McCullagh; Ken Paterson; Vanda Markovic-Pekovic; Andrew Martin; Jutta Piessnegger; Gisbert Selke; Catherine Sermet; Steven Simoens; Cankat Tulunay; Dominik Tomek; Luka Vončina; Vera Vlahovic-Palcevski; Janet Wale; Michael Wilcock; Magdalena Wladysiuk; Menno van Woerkom; Corrine Zara; Lars L Gustafsson
Journal:  Front Pharmacol       Date:  2013-05-14       Impact factor: 5.810
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.